ESR1 and breast neoplasm: Immunohistochemical analysis of tissue microarrays found that protein expression of NSUN2 was upregulated in 34% of analyzed breast tumors (n = 89 tumors), but that this upregulation showed no correlation with the expression of Ki67, Estrogen Receptor (ER) status, or MYC amplification [95].